Taken together, our results strongly suggested that ER-α66-mediated genomic estrogen signaling is important in cell differentiation, which is attenuated in ER-positive breast cancer stem/progenitor cells presumably through re-distribution and down-regulation of ER-α66 protein. Here, ESR1 is linked to breast carcinoma.